Hefiya
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hefiya, covering 2026-02-16 to 2026-02-16. Get the full timeline:
Most recent: EMA Authorised: Hefiya (adalimumab) — Sandoz GmbH
1 regulatory and trial event tracked for Hefiya, covering 2026-02-16 to 2026-02-16. Get the full timeline:
Most recent: EMA Authorised: Hefiya (adalimumab) — Sandoz GmbH